Donate Now

Schedule an Appointment

702.483.6000

Keep Memory Alive

702.263.9797

Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense

June 8, 2021

Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense

The Food and Drug Administration’s decision on Monday to approve a new Alzheimer’s medication over the fierce objections of its scientific advisers sets into motion one of the most controversial drug introductions in years.